alexa
Reach Us +44-1904-929220
Search For Biomarkers In Blood Serum: A Proteomic Investigation In Different Infectious Diseases And Gliomas | 3596
ISSN-2155-9929

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Search for biomarkers in blood serum: A proteomic investigation in different infectious diseases and gliomas

3rd International Conference on Biomarkers & Clinical Research

Sanjeeva Srivastava, Sandipan Ray, Rajneesh Srivastava, Kishore Gollapalli, Karnika Tripathi, and Vineet Vaibhav

ScientificTracks Abstracts: J Mol Biomark Diagn

DOI: 10.4172/2155-9929.S1.009

Abstract
P rotein biomarkers that can assist in early detection, monitoring disease progression and following prognosis in response to the therapeutic interventions have valuable impact on clinical research. Analysis of serum proteome is an effective approach for deciphering disease pathobiology and identification of diagnostic/prognostic marker proteins, since this biological fluid has constant intimacy with different body parts and contains miscellaneous classes of proteins released by diseased tissues. This study was conducted to analyze alterations in the human serum proteome in different pathogenic infections and glioblastoma multiforme (GBM) to identify serum protein markers of these fatal human diseases and to obtain mechanistic insights about disease pathogenesis and host immune response. In this analysis serum samples from falciparum malaria, vivax malaria, dengue fever, leptospirosis, GBM subjects and healthy controls were investigated using various proteomic techniques. Multiple immunoassay-based approaches were also employed to validate the results obtained in gel and MS-based proteomic analysis. A panel of identified proteins consists of six candidates; serum amyloid A, hemopexin, apolipoprotein E, haptoglobin, retinol- binding protein and apolipoprotein A-I was used to build statistical sample class prediction models employing PLSDA and other classification methods to predict the clinical phenotypic classes which achieved very high prediction accuracy. This is presumably the first comprehensive analysis to demonstrate discrimination among multiple human diseases based on serum protein expression profiles.
Biography
Dr. Sanjeeva Srivastava is Group Leader of Proteomics Laboratory at IIT Bombay India. He obtained his Ph.D. from the University of Alberta and post-doc from Harvard Medical School. Current research in this group centers on using HT proteomics for biomarker discovery in various diseases, studying protein interactions and drug target discovery. He is recipient of several awards including National Young Scientist Award (Canada), Young Scientist Awards (India) and the Apple Research Technology Support Award (UK). He serves as Editor-in-Chief for International Journal of Genomics and Proteomics, and Associate Editor for several international journals, including Journal of Integrated OMICS.
Relevant Topics
Top